SG Americas Securities
COGT icon

SG Americas Securities’s Cogent Biosciences COGT Stock Holding History

SG Americas Securities’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$257K Sell
6,629
-29,898
-82% -$1.05M ﹤0.01% 2673
2026
Q1 		$1.41M Sell
36,527
-1,107
-3% -$40.9K ﹤0.01% 1563
2025
Q4 		$1.34M Buy
37,634
+11,729
+45% +$330K ﹤0.01% 1784
2025
Q3 		$372K Buy
+25,905
New +$307K ﹤0.01% 2340
2025
Q2 		– Sell
-947,797
Closed -$5.68M – 3048
2025
Q1 		$5.68M Sell
947,797
-16,915
-2% -$133K 0.02% 432
2024
Q4 		$7.53M Buy
964,712
+932,179
+2,865% +$9.29M 0.03% 270
2024
Q3 		$351K Buy
+32,533
New +$317K ﹤0.01% 2001
2024
Q2 		– Sell
-14,750
Closed -$99K – 2923
2024
Q1 		$99K Sell
14,750
-302,659
-95% -$1.87M ﹤0.01% 2571
2023
Q4 		$1.87M Buy
317,409
+212,687
+203% +$1.63M 0.02% 712
2023
Q3 		$1.02M Buy
104,722
+65,843
+169% +$781K 0.01% 1248
2023
Q2 		$460K Sell
38,879
-121,962
-76% -$1.4M ﹤0.01% 1434
2023
Q1 		$1.74M Buy
160,841
+138,148
+609% +$1.77M 0.02% 751
2022
Q4 		$262K Sell
22,693
-1,774
-7% -$22K ﹤0.01% 2022
2022
Q3 		$365K Buy
24,467
+7,418
+44% +$102K ﹤0.01% 1821
2022
Q2 		$154K Buy
+17,049
New +$116K ﹤0.01% 2849
2021
Q4 		– Sell
-19,307
Closed -$162K – 3440
2021
Q3 		$162K Buy
+19,307
New +$148K ﹤0.01% 3369

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SG Americas Securities's COGT Position: Q2 2026 in Review

SG Americas Securities reduced its Cogent Biosciences (COGT) stake by 82% in Q2 2026, selling an estimated $1.05M and leaving 6,629 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #2673.

SG Americas Securities first reported a position in COGT in Q3 2021 and has held it in 16 quarters since. The position peaked at $7.53M in Q4 2024. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • SG Americas Securities held 6,629 shares of Cogent Biosciences worth $257K as of Q2 2026.
  • SG Americas Securities sold 29,898 Cogent Biosciences shares in Q2 2026, an estimated $1.05M.
  • Cogent Biosciences made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2673 holding.
  • SG Americas Securities first reported a position in Cogent Biosciences in Q3 2021 and has held it in 16 quarters since.
  • SG Americas Securities's Cogent Biosciences position peaked at $7.53M in Q4 2024.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.